UOC
REVH

UBS O'Connor’s Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock REVH Stock Holding History

UBS O'Connor’s Portfolio REVH Stock Details REVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-619,304
Closed -$6.09M – 853
2022
Q3 		$6.09M Sell
619,304
-61,998
-9% -$608K 0.07% 179
2022
Q2 		$6.65M Buy
+681,302
New +$6.66M 0.07% 174
2022
Q1 		– Sell
-669,295
Closed -$6.5M – 720
2021
Q4 		$6.5M Buy
669,295
+268,903
+67% +$2.63M 0.06% 145
2021
Q3 		$3.9M Hold
400,392
– – 0.03% 370
2021
Q2 		$3.93M Buy
+400,392
New +$3.94M 0.04% 324

UBS O'Connor's REVH Position: Q4 2022 in Review

UBS O'Connor sold out of Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) in Q4 2022, closing a stake of 619,304 shares — an estimated $6.09M sold.

UBS O'Connor first reported a position in REVH in Q2 2021 and held it in 5 quarters. The position peaked at $6.65M in Q2 2022. 0 funds tracked by Wall St. Rank hold REVH as of Q4 2022.

  • UBS O'Connor reported no remaining Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 619,304 Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock shares in Q4 2022, an estimated $6.09M.
  • UBS O'Connor first reported a position in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in Q2 2021 and held it in 5 quarters.
  • UBS O'Connor's Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position peaked at $6.65M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.